| Literature DB >> 25587337 |
Gholamhossein Mehralian1, Nazila Yousefi1, Farshad Hashemian2, Hanieh Maleksabet2.
Abstract
The present study aimed to evaluate pharmacy practice regarding dietary supplements in Tehran (I.R. Iran). So, the factors affecting on pharmacists' practice including their knowledge, attitude, and some underlying factors were evaluated. This is an observational knowledge; attitude and practice (KAP) study. The unit of analysis include pharmacies practice located in Tehran. The data was collected in 2013 via an anonymous, self-administered; postal questionnaire consisted of demographic information, knowledge (subjective and objective questions), attitude, and practice evaluation part. Descriptive and inferential statistics were performed using SPSS. This study showed that although the knowledge has a significant effect on attitude and practice, the attention should be paid on other underlying factors such as experience, pharmacy ownership situation and academic degree which might have positive impact on pharmacists' practice. According to this study, although many underlying factors such as experience, university and pharmacy ownership have impact on pharmacy practice regarding dietary supplements, the most attention should paid to knowledge as the main factor and more attention should be paid to training on dietary supplement could be recommended.Entities:
Keywords: Community pharmacist; Dietary supplement; Food Supplementation; Iran; KAP study
Year: 2014 PMID: 25587337 PMCID: PMC4232814
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Descriptive and reliability analysis of KAP questionnaire
|
|
|
|
|
|---|---|---|---|
|
| |||
| Generally I have sufficient information toward dietary supplement. | 3.46 | 0.73 | 0.86 |
| I have sufficient information about efficiency and effectiveness of dietary supplement. | 2.89 | 0.87 | |
| I have sufficient information about adverse effects of dietary supplement. | 3.32 | 0.77 | |
| I have sufficient information about dosage and administration of dietary supplement. | 2.96 | 0.81 | |
| I have sufficient information about indications of some dietary supplement in specific groups such as pregnancy, breast feeding, pediatric and geriatric. | 3.25 | 0.77 | |
| I have sufficient information about drug-supplement interactions. | 2.99 | 0.86 | |
| I have sufficient information about contraindication of dietary supplement and in special groups of patient for example with hypertension or kidney disease. | 2.85 | 0.79 | |
|
| |||
| Dietary supplements have a positive impact on public health. | 2.96 | 0.87 | 0.61 |
| Therapeutic efficacy of dietary supplement may be considerable. | 3.63 | 0.78 | |
| Pharmacists should be knowledgeable about supplements and consulting in this field is part of pharmacist’s duties. | 3.31 | 0.88 | |
| 4.11 | 0.72 | ||
| Supplement should dispense according to the nutritionist or physicians prescription. | 2.25 | 0.90 | |
| Supplement should be sold in pharmacies under pharmacist’s supervision. | 3.03 | 0.87 | |
| Supplements considered as an important source of profit for pharmacies. | 3.89 | 0.87 | |
| Price is important factor for recommending supplements to customers. | 3.29 | 0.96 | |
| Customers usually are influenced by Pharmacist’s comments about supplements. | 3.68 | 0.90 | |
|
| |||
| I always allot enough time for giving advice to customers on supplements. | 3.91 | 0.77 | 0.81 |
| I’ve studied some scientific references regarding to supplements. | 3.60 | 0.75 | |
| I could refer to valid Web Pages and scientific references relevant to dietary supplement in case of needed. | 3.16 | 0.81 | |
| I always recommend supplements to consumers with confidence about their effectiveness. | 3.27 | 0.86 | |
| I always inform consumers about possible adverse effects of dietary supplements. | 3.41 | 0.85 | |
| I always advise consumers about dosage and administration of supplements. | 3.44 | 0.82 | |
| I always ask consumer’s medical history when I recommend these products. | 3.57 | 0.75 | |
| I always check whether particular supplement taken by consumer interact with her/his prescription medicines. | 3.56 | 0.77 | |
| I always inform consumers about drug-supplement interactions. | 3.50 | 0.84 | |
| I have self-confidence for recommending supplement. | 3.43 | 0.87 | |
KAP: knowledge, attitude, practice; SD: standard deviation
Demographic and Background Characteristics of participants (N=500).
|
|
|
|
|---|---|---|
|
| Male | 329 (65.8) |
| Female | 171 (34.2) | |
|
| Under 25 | 165 (33.0) |
| 25-35 | 186 (37.2) | |
| 36-45 | 89 (17.8) | |
| Above 45 | 60 (12.0) | |
|
| Pharmacy student | 102 (20.4) |
| Pharm.D | 374 (74.8) | |
| PhD | 24 (4.8) | |
|
| Less than 5 | 251 (50.2) |
| 5-10 | 122 (24.4) | |
| 11-20 | 78 (15.6) | |
| More than 20 | 49 (9.8) | |
|
| Temporary pharmacist | 186 (37.2) |
| Technical responsible | 216 (43.2) | |
| Owner | 98 (19.6) |
Descriptive results of objective practical questions about pharmacists' knowledge (N=500).
|
|
|
|---|---|
|
| 23 (4.6) |
|
| 288 (57.6) |
|
| 105 (21.0) |
|
| 63 (12.6) |
|
| 21 (4.2) |
Descriptive, correlation and factor analysis
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
| 3.10 | 0.59 | 0.89 | 0.55 | 0.65-0.80 | 1 | 0.29 | 0.43 |
|
| 3.33 | 0.34 | 0.56 | 0.63 | 0.53-0.70 | 0.29 | 1 | 0.31 |
|
| 3.51 | 0.60 | 0.87 | 0.61 | 0.64-0.74 | 0.43 | 0.31 | 1 |
SD: standard deviation; KMO: Kaiser-Mayer-Olkin; AVE: Average Variance Extracted
Correlation is significant at the 0.01 level (2-tailed).
Participants’ characteristics and KAP components
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
| Female | 230.41 | 248.69 | 249.42 | 256.67 |
| Male | 289.16 | 253.99 | 252.58 | 238.64 | |
| Sig. (2-tailed) | .000 | 0.696 | 0.815 | 0.138 | |
|
| Under 25 | 237.57 | 214.11 | 187.98 | 248.15 |
| 25-35 | 254.07 | 256.72 | 274.35 | 250.11 | |
| 35-45 | 267.08 | 286.23 | 281.97 | 269.59 | |
| Over 45 | 250.39 | 278.30 | 301.84 | 229.86 | |
| Sig. (2-tailed) | 0.452 | 0.000 | 0.000 | 0.316 | |
|
| Less than 5 | 238.84 | 220.62 | 211.30 | 242.86 |
| 5-10 | 272.92 | 278.23 | 293.08 | 254.01 | |
| 11-20 | 260.49 | 285.19 | 286.19 | 279.49 | |
| More than 20 | 238.52 | 279.30 | 288.44 | 234.74 | |
| Sig. (2-tailed) | 0.149 | 0.000 | 0.000 | 0.131 | |
|
| Student | 156.48 | 218.94 | 198.47 | 251.09 |
| Pharm.D | 273.34 | 256.24 | 260.96 | 248.43 | |
| PhD | 294.25 | 295.19 | 308.65 | 280.27 | |
| Sig. (2-tailed) | 0.000 | 0.020 | 0.000 | 0.503 | |
|
| Non-governmental | 222.59 | 252.82 | 239.58 | 254.91 |
| governmental | 270.76 | 248.18 | 257.99 | 246.49 | |
| Abroad | 447.50 | 416.50 | 452.50 | 448.00 | |
| Sig. (2-tailed) | 0.000 | 0.481 | 0.138 | 0.238 | |
|
| Duty of director | 184.94 | 222.92 | 208.87 | 247.42 |
| Technical responsible | 280.05 | 261.25 | 262.78 | 246.02 | |
| Owner | 309.80 | 279.16 | 302.44 | 266.23 | |
| Sig. (2-tailed) | 0.000 | 0.003 | 0.000 | 0.402 | |